Catheter Precision Highlights Non-Invasive Cardiac Treatment Using VIVO

Catheter Precision, Inc., a medical device company, announced a new clinical publication in HeartRhythm Case Reports about a novel procedure using stereotactic radioablation (STAR) for heart arrhythmia. This technique uses external photon beams to target problematic heart areas. The procedure highlights the importance of pre-procedural information, where VIVO provided more precise locations compared to traditional methods. This technology was crucial in the successful treatment of a patient, who remained asymptomatic four months post-procedure.

David Jenkins, CEO, emphasized the potential of combining traditional ECGs with 3D imaging and VIVO technology for patient-specific solutions. VIVO's role in pre-procedural planning is highlighted as essential for potentially broader future use.